Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors.

AlDubayan SH, Pyle LC, Gamulin M, Kulis T, Moore ND, Taylor-Weiner A, Hamid AA, Reardon B, Wubbenhorst B, Godse R, Vaughn DJ, Jacobs LA, Meien S, Grgic M, Kastelan Z, Markt SC, Damrauer SM, Rader DJ, Kember RL, Loud JT, Kanetsky PA, Greene MH, Sweeney CJ, Kubisch C, Nathanson KL, Van Allen EM, Stewart DR, Lessel D; Regeneron Genetics Center (RGC) Research Team.

JAMA Oncol. 2019 Jan 24. doi: 10.1001/jamaoncol.2018.6477. [Epub ahead of print]

PMID:
30676620
2.

Autologous Stem-Cell Transplantation Outcomes for Relapsed Metastatic Germ-Cell Tumors in the Modern Era.

Hamid AA, Markt SC, Vicier C, McDermott K, Richardson P, Ho VT, Sweeney CJ.

Clin Genitourin Cancer. 2019 Feb;17(1):58-64.e1. doi: 10.1016/j.clgc.2018.09.009. Epub 2018 Sep 19.

PMID:
30309761
3.

Smoking cessation among men following cancer diagnosis: a matched cohort study.

Robinson CD, Gonzalez-Feliciano A, Mucci LA, Markt SC.

J Cancer Surviv. 2018 Dec;12(6):786-793. doi: 10.1007/s11764-018-0715-7. Epub 2018 Oct 9.

PMID:
30302603
4.

A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG.

Pernar CH, Ebot EM, Pettersson A, Graff RE, Giunchi F, Ahearn TU, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Stopsack KH, Gazeeva E, Lis RT, Parmigiani G, Rimm EB, Finn SP, Giovannucci EL, Fiorentino M, Mucci LA.

Eur Urol. 2018 Oct 6. pii: S0302-2838(18)30730-9. doi: 10.1016/j.eururo.2018.09.041. [Epub ahead of print]

PMID:
30301696
5.

Association between Trichomonas vaginalis and prostate cancer mortality.

Tsang SH, Peisch SF, Rowan B, Markt SC, Gonzalez-Feliciano AG, Sutcliffe S, Platz EA, Mucci LA, Ebot EM.

Int J Cancer. 2018 Sep 22. doi: 10.1002/ijc.31885. [Epub ahead of print]

PMID:
30242839
6.

Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.

Preston MA, Gerke T, Carlsson SV, Signorello L, Sjoberg DD, Markt SC, Kibel AS, Trinh QD, Steinwandel M, Blot W, Vickers AJ, Lilja H, Mucci LA, Wilson KM.

Eur Urol. 2019 Mar;75(3):399-407. doi: 10.1016/j.eururo.2018.08.032. Epub 2018 Sep 17.

PMID:
30237027
7.

Early-Life Alcohol Intake and High-Grade Prostate Cancer: Results from an Equal-Access, Racially Diverse Biopsy Cohort.

Michael J, Howard LE, Markt SC, De Hoedt A, Bailey C, Mucci LA, Freedland SJ, Allott EH.

Cancer Prev Res (Phila). 2018 Oct;11(10):621-628. doi: 10.1158/1940-6207.CAPR-18-0057. Epub 2018 Aug 23.

PMID:
30139875
8.

Family History of Breast or Prostate Cancer and Prostate Cancer Risk.

Barber L, Gerke T, Markt SC, Peisch SF, Wilson KM, Ahearn T, Giovannucci E, Parmigiani G, Mucci LA.

Clin Cancer Res. 2018 Dec 1;24(23):5910-5917. doi: 10.1158/1078-0432.CCR-18-0370. Epub 2018 Aug 6.

PMID:
30082473
9.

Geographic Differences in Baseline Prostate Inflammation and Relationship with Subsequent Prostate Cancer Risk: Results from the Multinational REDUCE Trial.

Allott EH, Markt SC, Howard LE, Vidal AC, Moreira DM, Castro-Santamaria R, Andriole GL, Mucci LA, Freedland SJ.

Cancer Epidemiol Biomarkers Prev. 2018 Jul;27(7):783-789. doi: 10.1158/1055-9965.EPI-18-0076. Epub 2018 Apr 18.

PMID:
29669727
10.

Sex differences in the associations of obstructive sleep apnoea with epidemiological factors.

Huang T, Lin BM, Markt SC, Stampfer MJ, Laden F, Hu FB, Tworoger SS, Redline S.

Eur Respir J. 2018 Mar 15;51(3). pii: 1702421. doi: 10.1183/13993003.02421-2017. Print 2018 Mar.

PMID:
29449424
11.

Insurance status and cancer treatment mediate the association between race/ethnicity and cervical cancer survival.

Markt SC, Tang T, Cronin AM, Katz IT, Howitt BE, Horowitz NS, Lee LJ, Wright AA.

PLoS One. 2018 Feb 15;13(2):e0193047. doi: 10.1371/journal.pone.0193047. eCollection 2018.

12.

Reply to Christian D. Fankhauser, Nico C. Grossmann, Joerg Beyer, and Thomas Hermanns' Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70.

Kamran SC, Seisen T, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ.

Eur Urol. 2018 Apr;73(4):e96-e97. doi: 10.1016/j.eururo.2017.12.026. Epub 2018 Jan 19. No abstract available.

PMID:
29358058
13.

Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer.

Graff RE, Ahearn TU, Pettersson A, Ebot EM, Gerke T, Penney KL, Wilson KM, Markt SC, Pernar CH, Gonzalez-Feliciano AG, Song M, Lis RT, Schmidt DR, Vander Heiden MG, Fiorentino M, Giovannucci EL, Loda M, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):193-200. doi: 10.1158/1055-9965.EPI-17-0547. Epub 2017 Nov 22.

14.

Midlife metabolic factors and prostate cancer risk in later life.

Dickerman BA, Torfadottir JE, Valdimarsdottir UA, Wilson KM, Steingrimsdottir L, Aspelund T, Batista JL, Fall K, Giovannucci E, Sigurdardottir LG, Tryggvadottir L, Gudnason V, Markt SC, Mucci LA.

Int J Cancer. 2018 Mar 15;142(6):1166-1173. doi: 10.1002/ijc.31142. Epub 2017 Nov 16.

PMID:
29114858
15.

Reply to Aditya Bagrodia, Solomon Woldu, David F. Penson, Alexander Kutikov, and Samuel D. Kaffenberger's Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70.

Seisen T, Kamran SC, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ.

Eur Urol. 2018 Apr;73(4):e100-e101. doi: 10.1016/j.eururo.2017.10.013. Epub 2017 Nov 3. No abstract available.

PMID:
29108659
16.

Smoking and Disease Outcomes in Patients With Malignant Germ Cell Tumors.

O'Donnell E, Markt SC, Miller R, Bernard B, Albiges L, Beard C, Sweeney C.

Clin Genitourin Cancer. 2017 Aug 3. pii: S1558-7673(17)30234-3. doi: 10.1016/j.clgc.2017.07.024. [Epub ahead of print]

PMID:
28851592
17.

Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended Chemotherapy.

Miller RE, Markt SC, O'Donnell E, Bernard B, Albiges LK, Beard C, Sweeney CJ.

Eur Urol Focus. 2017 Dec;3(6):621-628. doi: 10.1016/j.euf.2016.10.005. Epub 2016 Oct 26.

PMID:
28753801
18.

Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer.

Kamran SC, Seisen T, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ.

Eur Urol. 2018 Feb;73(2):262-270. doi: 10.1016/j.eururo.2017.06.013. Epub 2017 Jul 4.

PMID:
28687143
19.

A Walking Intervention Among Men With Prostate Cancer: A Pilot Study.

Pernar CH, Fall K, Rider JR, Markt SC, Adami HO, Andersson SO, Valdimarsdottir U, Andrén O, Mucci LA.

Clin Genitourin Cancer. 2017 Dec;15(6):e1021-e1028. doi: 10.1016/j.clgc.2017.05.022. Epub 2017 May 31.

20.

Authors' reply to Rishniw.

Markt SC, Mucci LA.

BMJ. 2017 Jun 16;357:j2910. doi: 10.1136/bmj.j2910. No abstract available.

PMID:
28623236
21.

Sniffing out significant "Pee values": genome wide association study of asparagus anosmia.

Markt SC, Nuttall E, Turman C, Sinnott J, Rimm EB, Ecsedy E, Unger RH, Fall K, Finn S, Jensen MK, Rider JR, Kraft P, Mucci LA.

BMJ. 2016 Dec 13;355:i6071. doi: 10.1136/bmj.i6071.

22.

Sleep disruption, chronotype, shift work, and prostate cancer risk and mortality: a 30-year prospective cohort study of Finnish twins.

Dickerman BA, Markt SC, Koskenvuo M, Hublin C, Pukkala E, Mucci LA, Kaprio J.

Cancer Causes Control. 2016 Nov;27(11):1361-1370. Epub 2016 Oct 12.

23.

Snus use, smoking and survival among prostate cancer patients.

Wilson KM, Markt SC, Fang F, Nordenvall C, Rider JR, Ye W, Adami HO, Stattin P, Nyrén O, Mucci LA.

Int J Cancer. 2016 Dec 15;139(12):2753-2759. doi: 10.1002/ijc.30411.

24.

Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors.

Markt SC, Lago-Hernandez CA, Miller RE, Mahal BA, Bernard B, Albiges L, Frazier LA, Beard CJ, Wright AA, Sweeney CJ.

Cancer. 2016 Oct 15;122(20):3127-3135. doi: 10.1002/cncr.30159. Epub 2016 Aug 8.

25.

Pineal Gland Volume Assessed by MRI and Its Correlation with 6-Sulfatoxymelatonin Levels among Older Men.

Sigurdardottir LG, Markt SC, Sigurdsson S, Aspelund T, Fall K, Schernhammer E, Rider JR, Launer L, Harris T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA.

J Biol Rhythms. 2016 Oct;31(5):461-9. doi: 10.1177/0748730416656948. Epub 2016 Jul 22.

26.

CHALLENGE Trial 1 Year Feasibility Results-Letter.

Pernar CH, Markt SC, McKay RR, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2016 Aug;25(8):1277. doi: 10.1158/1055-9965.EPI-16-0393. Epub 2016 Jul 14. No abstract available.

27.

Alcohol intake, drinking patterns, and prostate cancer risk and mortality: a 30-year prospective cohort study of Finnish twins.

Dickerman BA, Markt SC, Koskenvuo M, Pukkala E, Mucci LA, Kaprio J.

Cancer Causes Control. 2016 Sep;27(9):1049-58. doi: 10.1007/s10552-016-0778-6. Epub 2016 Jun 28.

28.

Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression.

Graff RE, Pettersson A, Lis RT, Ahearn TU, Markt SC, Wilson KM, Rider JR, Fiorentino M, Finn S, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Mucci LA.

Am J Clin Nutr. 2016 Mar;103(3):851-60. doi: 10.3945/ajcn.115.118703. Epub 2016 Jan 27.

29.

Sleep Duration and Disruption and Prostate Cancer Risk: a 23-Year Prospective Study.

Markt SC, Flynn-Evans EE, Valdimarsdottir UA, Sigurdardottir LG, Tamimi RM, Batista JL, Haneuse S, Lockley SW, Stampfer M, Wilson KM, Czeisler CA, Rider JR, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):302-8. doi: 10.1158/1055-9965.EPI-14-1274. Epub 2015 Dec 16.

30.

ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3).

Markt SC, Shui IM, Unger RH, Urun Y, Berg CD, Black A, Brennan P, Bueno-de-Mesquita HB, Gapstur SM, Giovannucci E, Haiman C, Henderson B, Hoover RN, Hunter DJ, Key TJ, Khaw KT, Canzian F, Larranga N, Le Marchand L, Ma J, Naccarati A, Siddiq A, Stampfer MJ, Stattin P, Stevens VL, Stram DO, Tjønneland A, Travis RC, Trichopoulos D, Ziegler RG, Lindstrom S, Kraft P, Mucci LA, Choueiri TK, Wilson KM.

Prostate. 2015 Nov;75(15):1677-81. doi: 10.1002/pros.23035. Epub 2015 Aug 13.

31.

Insufficient Sleep and Risk of Prostate Cancer in a Large Swedish Cohort.

Markt SC, Grotta A, Nyren O, Adami HO, Mucci LA, Valdimarsdottir UA, Stattin P, Bellocco R, Lagerros YT.

Sleep. 2015 Sep 1;38(9):1405-10. doi: 10.5665/sleep.4978.

32.

Circadian clock genes and risk of fatal prostate cancer.

Markt SC, Valdimarsdottir UA, Shui IM, Sigurdardottir LG, Rider JR, Tamimi RM, Batista JL, Haneuse S, Flynn-Evans E, Lockley SW, Czeisler CA, Stampfer MJ, Launer L, Harris T, Smith AV, Gudnason V, Lindstrom S, Kraft P, Mucci LA.

Cancer Causes Control. 2015 Jan;26(1):25-33. doi: 10.1007/s10552-014-0478-z. Epub 2014 Nov 12.

33.

Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly men.

Sigurdardottir LG, Markt SC, Rider JR, Haneuse S, Fall K, Schernhammer ES, Tamimi RM, Flynn-Evans E, Batista JL, Launer L, Harris T, Aspelund T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA.

Eur Urol. 2015 Feb;67(2):191-4. doi: 10.1016/j.eururo.2014.07.008. Epub 2014 Aug 5.

34.

5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer.

Preston MA, Wilson KM, Markt SC, Ge R, Morash C, Stampfer MJ, Loda M, Giovannucci E, Mucci LA, Olumi AF.

JAMA Intern Med. 2014 Aug;174(8):1301-7. doi: 10.1001/jamainternmed.2014.1600.

35.

Genetic variation across C-reactive protein and risk of prostate cancer.

Markt SC, Rider JR, Penney KL, Schumacher FR, Epstein MM, Fall K, Sesso HD, Stampfer MJ, Mucci LA.

Prostate. 2014 Jul;74(10):1034-42. doi: 10.1002/pros.22820. Epub 2014 May 20.

36.

HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays.

Lin SW, Ghosh A, Porras C, Markt SC, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Pinto LA, Gonzalez P, Wentzensen N, Esser MT, Matys K, Meuree A, Quint W, van Doorn LJ, Herrero R, Hildesheim A, Safaeian M; Costa Rican Vaccine Trial Group.

PLoS One. 2013;8(1):e53067. doi: 10.1371/journal.pone.0053067. Epub 2013 Jan 2.

37.

Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotesting.

Markt SC, Rodriguez AC, Burk RD, Hildesheim A, Herrero R, Wacholder S, Hutchinson M, Schiffman M.

J Infect Dis. 2012 Feb 1;205(3):498-505. doi: 10.1093/infdis/jir746. Epub 2011 Dec 5.

Supplemental Content

Loading ...
Support Center